A Trial of Lu AG13909 in Adult Participants With Cushing's Disease

NCT06471829 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Cushing's Disease

Interventions

DRUG: Lu AG13909

Sponsor

H. Lundbeck A/S